Volume 11
Issue 2 April

Article 5

Comment on Electron Beam Computerized Tomography
Patrick T H Ko

Follow this and additional works at: https://www.jhkcc.com.hk/journal

Recommended Citation
Patrick T H Ko, Comment on Electron Beam Computerized Tomography Journal of the Hong Kong College of
Cardiology 2003;11(2) https://doi.org/10.55503/2790-6744.1149
This Letter to the Editor is brought to you for free and open access by Journal of the Hong Kong College of Cardiology. It has been
accepted for inclusion in Journal of the Hong Kong College of Cardiology by an authorized editor of Journal of the Hong Kong
College of Cardiology.

Letter to the Editor
Comment on Electron Beam Computerized Tomography
Dear Editor,
In the past several years, controversy has loomed
over the use of electron beam computerized tomography
(EBCT) in the detection of plaques in the coronary
arteries. While it has become fashionable among the
lay public, many attracted by prominent and smart
advertisements posted on public buses etc., responses
from cardiologists, especially those working in
academic centers, have remained skeptical to lukewarm.
This has been the phenomenon internationally as well
as in Hong Kong.
There is little disagreement that EBCT is able to
detect calcium in the coronary artery, and that the
presence of calcium indicates atherosclerotic plaque.
As such, it can be regarded as a surrogate marker for
coronary artery disease. However, it is well known that
any surrogate marker or risk factor such as hypercholesterolemia or hypertension detected in any
individual does not necessarily indicate an immediate
risk of an impending heart attack. In the vast majority
of people, the atherosclerotic process is a slow and
insidious process, and people with atherosclerotic
plaques may remain symptom-free for years or even
decades, before clinical manifestations develop in the
form of angina, unstable angina, acute coronary
syndrome, myocardial infarction or heart failure. If
EBCT is going to be a useful test for asymptomatic
individuals, it should be able to predict near-term future
events in patients at risk. It should also be able to
supercede other readily available and relatively
inexpensive clinical data collection such as age, gender,
cigarette smoking, blood pressure, or laboratory
measurements of LDL-cholesterol, glucose etc. by
offering an incremental value to the risk assessment by
the Framingham and National Cholesterol Education
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Program risk factor determination. 1 The published
literature, however, does not support the claim that
EBCT can offer additional value to conventional risk
factor assessment as above-mentioned.2
Various investigators have, in the last decade,
reported the sensitivity, specificity and predictive
accuracy of EBCT, as compared to coronary
angiography, the diagnostic gold standard. For example,
Rumberger et al3 reported, out of a total of 251 patients,
a true positive of 176, a true negative of 29, a false
negative of 1 and a false positive of 45. The overall
sensitivity was very high at 99.84%, but the specificity
was very low at 25.7%, yielding an overall predictive
accuracy of 81.7%. In another study, Kennedy et al4
reported in 1998 out of 368 patients a true positive of
151, true negative of 64, false negative of 7 and false
positive of 146, yielding a sensitivity of 95.6% and a
specificity of 30.5%. The overall predictive accuracy
was 58.4%. In an attempt to pool the published data
from the literature, a meta-analysis was performed by
the American College of Cardiology Task Force on
Clinical Expert Consensus Documents.5 A total of 3683
patients were pooled from 16 studies. The sensitivity
ranged from 67.9% to 100% with a weighted average
(adjusted according to sample size since some of the
study populations were rather small) of 80.4%. The
specificity ranged from 21.4% to 100%, with a weighted
average of 39.9%. The predictive accuracy ranged from
40.9% to 94.9%, with a weighted average of 59.1%.
From such meta-analysis, one can see that EBCT,
limited by its present technology, is highly sensitive in
detecting calcified plaques, but not specific or accurate
in so far as the diagnosis or the staging of clinically
significant coronary artery disease is concerned. Despite
the high sensitivity, the high false positive rates often
induce unnecessary anxiety, and even panic in some
cases. Among individuals who may not be at risk for
coronary events in the near term, many of these do go
on to further investigations such as myocardial isotope
scanning, cardiac magnetic resonance perfusion study
or even coronary angiography, only to find out that many
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of them turn out to have no significant coronary artery
disease. The premise of EBCT is thus defeated.
Furthermore, there is increasing evidence from
the literature that inflammation of the arterial wall
covering the plaque plays a very important role in
causing heart attacks by acute rupture of plaques that
are often, in as many as 50% or more of the cases, soft
and fatty, rather than hard or calcified. 6 Many
cardiologists believe that as plaques become calcified,
the vessel lumen actually expands via a process of
remodeling. In fact, calcification may even act as a
lattice, holding the plaque in place and preventing the
plaque from rupturing.7 Calcium in the walls of the
artery may be protective in a sense, and not really such
an alarming signal after all! Researchers are now racing
to find an imaging technique that will detect such
"vulnerable" or "hot" plaques. When such a technique
is indeed in place, and proven clinically relevant and
useful, assessment of calcium scores could become moot
or obsolete.
False negative rates are fortunately low, but albeit
the small number, this is a group of patients not to be
taken too lightly, since they are a high risk group of
patients, who are not likely going to see cardiologists
until such times when they develop acute coronary
syndrome or myocardial infarction, having been
"falsely" reassured. They are, therefore, at double risk.
In the last issue of the journal, 8 Thomson and
White's article: "The Role of Ultra-fast Computed
Tomography in the Assessment of Coronary Disease"
is well written and timely. The authors have done a
critical analysis of the use of EBCT as a screening tool
for asymptomatic patients, as a diagnostic evaluation
for patients with symptoms of coronary artery disease,
and as follow-up evaluation for patients with known
coronary artery disease. This highly informative paper
should offer the clinician a welcome and useful guide
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to the current use and limitation of EBCT in clinical
practice. Physicians should exercise caution in the
interpretation of the EBCT calcium scores, taken into
consideration that this technology is still new and far
from perfect. There is much room for further research
in this area.

Yours faithfully
Dr Patrick T H Ko
M.D.(Alberta), F.A.C.C., F.A.C.P., F.H.K.C.C, FHKAM(Med)
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